 | LE3 | Name: | N-{4-[(R)-methylsulfinyl]butyl}thioformamide | Formula: | C6 H13 N O S2 | SMILES: | O=S(CCCCNC=S)C | InChi: | InChI=1S/C6H13NOS2/c1-10(8)5-3-2-4-7-6-9/h6H,2-5H2,1H3,(H,7,9)/t10-/m1/s1 | Synonyms: | L-Sulforaphane, bound form | Definition date: | 2011-07-08 | Last modified: | 2024-09-27 | Release date: | 2012-09-28 | Identifier: | N-{4-[(R)-methylsulfinyl]butyl}thioformamide |
|
 | LEA | Name: | PENTANOIC ACID | Formula: | C5 H10 O2 | SMILES: | O=C(O)CCCC | InChi: | InChI=1S/C5H10O2/c1-2-3-4-5(6)7/h2-4H2,1H3,(H,6,7) | Synonyms: | VALERIC ACID | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | pentanoic acid |
|
 | LED | Name: | (4R)-5-OXO-L-LEUCINE | Formula: | C6 H11 N O3 | SMILES: | O=CC(C)CC(N)C(=O)O | InChi: | InChI=1S/C6H11NO3/c1-4(3-8)2-5(7)6(9)10/h3-5H,2,7H2,1H3,(H,9,10)/t4-,5+/m1/s1 | Definition date: | 2006-06-07 | Last modified: | 2024-09-27 | Identifier: | (4R)-5-oxo-L-leucine |
|
 | 2CA | Name: | BENZOFURAN-2-CARBOXYLIC ACID {(S)-3-METHYL-1-[3-OXO-1-(PYRIDIN-2-YLSULFONYL)AZEPAN-4-YLCARBAMOYL]BUTYL}AMIDE | Formula: | C26 H30 N4 O6 S | SMILES: | O=S(=O)(c1ncccc1)N4CC(=O)C(NC(=O)C(NC(=O)c3oc2ccccc2c3)CC(C)C)CCC4 | InChi: | InChI=1S/C26H30N4O6S/c1-17(2)14-20(29-26(33)23-15-18-8-3-4-10-22(18)36-23)25(32)28-19-9-7-13-30(16-21(19)31)37(34,35)24-11-5-6-12-27-24/h3-6,8,10-12,15,17,19-20H,7,9,13-14,16H2,1-2H3,(H,28,32)(H,29,33)/t19-,20-/m0/s1 | Definition date: | 2003-01-09 | Last modified: | 2024-09-27 | Identifier: | N-[(1S)-3-methyl-1-{[(4S)-3-oxo-1-(pyridin-2-ylsulfonyl)azepan-4-yl]carbamoyl}butyl]-1-benzofuran-2-carboxamide |
|
 | LEF | Name: | (4S)-5-FLUORO-L-LEUCINE | Formula: | C6 H12 F N O2 | SMILES: | FCC(CC(N)C(=O)O)C | InChi: | InChI=1S/C6H12FNO2/c1-4(3-7)2-5(8)6(9)10/h4-5H,2-3,8H2,1H3,(H,9,10)/t4-,5-/m0/s1 | Definition date: | 2003-05-13 | Last modified: | 2024-09-27 | Identifier: | (4S)-5-fluoro-L-leucine |
|
 | LEI | Name: | 3-sulfanyl-D-valine | Formula: | C5 H11 N O2 S | SMILES: | O=C(O)C(N)C(S)(C)C | InChi: | InChI=1S/C5H11NO2S/c1-5(2,9)3(6)4(7)8/h3,9H,6H2,1-2H3,(H,7,8)/t3-/m0/s1 | Synonyms: | D-PENICILLAMINE | Definition date: | 2009-05-16 | Last modified: | 2024-09-27 | Identifier: | 3-sulfanyl-D-valine |
|
 | LEN | Name: | 3-METHYLBUTAN-1-AMINE | Formula: | C5 H13 N | SMILES: | NCCC(C)C | InChi: | InChI=1S/C5H13N/c1-5(2)3-4-6/h5H,3-4,6H2,1-2H3 | Definition date: | 2003-05-27 | Last modified: | 2024-09-27 | Identifier: | 3-methylbutan-1-amine |
|
 | 2CO | Name: | S-HYDROPEROXYCYSTEINE | Formula: | C3 H7 N O4 S | SMILES: | O=C(O)C(N)CSOO | InChi: | InChI=1S/C3H7NO4S/c4-2(3(5)6)1-9-8-7/h2,7H,1,4H2,(H,5,6)/t2-/m0/s1 | Definition date: | 2007-01-16 | Last modified: | 2024-09-27 | Identifier: | S-hydroperoxy-L-cysteine |
|
 | LET | Name: | (Z)-N^6-{3-CARBOXY-1-[(4-CARBOXY-2-OXOBUTOXY)METHYL]PROPYLIDENE}-L-LYSINE | Formula: | C16 H26 N2 O8 | SMILES: | O=C(COC/C(=N/CCCCC(C(=O)O)N)CCC(=O)O)CCC(=O)O | InChi: | InChI=1S/C16H26N2O8/c17-13(16(24)25)3-1-2-8-18-11(4-6-14(20)21)9-26-10-12(19)5-7-15(22)23/h13H,1-10,17H2,(H,20,21)(H,22,23)(H,24,25)/b18-11+/t13-/m0/s1 | Synonyms: | 2-AMINO-6-[3-CARBOXY-1-(4-CARBOXY-2-OXO-BUTOXYMETHYL)-PROPYLIDENEAMINO]-HEXANOIC ACID | Definition date: | 2005-09-11 | Last modified: | 2024-09-27 | Identifier: | (E)-N~6~-{3-carboxy-1-[(4-carboxy-2-oxobutoxy)methyl]propylidene}-L-lysine |
|
 | LEU | Name: | LEUCINE | Formula: | C6 H13 N O2 | SMILES: | O=C(O)C(N)CC(C)C | InChi: | InChI=1S/C6H13NO2/c1-4(2)3-5(7)6(8)9/h4-5H,3,7H2,1-2H3,(H,8,9)/t5-/m0/s1 | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | L-leucine |
|
 | LF7 | Name: | 2-{[(1r,3s,5R,7S)-3-hydroxytricyclo[3.3.1.1~3,7~]decan-1-yl]amino}-1-{(2S)-2-[(E)-iminomethyl]pyrrolidin-1-yl}ethan-1-o
ne | Formula: | C17 H27 N3 O2 | SMILES: | O=C(N1C(CCC1)C=N)CNC24CC3CC(C2)CC(C3)(O)C4 | InChi: | InChI=1S/C17H27N3O2/c18-9-14-2-1-3-20(14)15(21)10-19-16-5-12-4-13(6-16)8-17(22,7-12)11-16/h9,12-14,18-19,22H,1-8,10-11H2/b18-9+/t12-,13+,14-,16+,17-/m0/s1 | Synonyms: | Vildagliptin, bound form | Definition date: | 2012-12-11 | Last modified: | 2024-09-27 | Release date: | 2013-05-15 | Identifier: | 2-{[(1r,3s,5R,7S)-3-hydroxytricyclo[3.3.1.1~3,7~]decan-1-yl]amino}-1-{(2S)-2-[(E)-iminomethyl]pyrrolidin-1-yl}ethan-1-one |
|
 | 2DA | Name: | 2',3'-DIDEOXYADENOSINE-5'-MONOPHOSPHATE | Formula: | C10 H14 N5 O5 P | SMILES: | O=P(O)(O)OCC3OC(n2cnc1c(ncnc12)N)CC3 | InChi: | InChI=1S/C10H14N5O5P/c11-9-8-10(13-4-12-9)15(5-14-8)7-2-1-6(20-7)3-19-21(16,17)18/h4-7H,1-3H2,(H2,11,12,13)(H2,16,17,18)/t6-,7+/m0/s1 | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | [(2S,5R)-5-(6-amino-9H-purin-9-yl)tetrahydrofuran-2-yl]methyl dihydrogen phosphate |
|
 | 2DB | Name: | (S)-(2,3-DIHYDROXYPROPOXY)TRIHYDROXYBORATE | Formula: | C3 H10 B O6 | SMILES: | O[B-](O)(O)OCC(O)CO | InChi: | InChI=1S/C3H10BO6/c5-1-3(6)2-10-4(7,8)9/h3,5-9H,1-2H2/q-1/t3-/m0/s1 | Definition date: | 2006-09-19 | Last modified: | 2024-09-27 | Identifier: | trihydroxy[(2S)-propane-1,2,3-triolato-kappaO~1~]borate(1-) |
|
 | LFI | Name: | 1-[3,5-bis(3-bromanylpropanoyl)-1,3,5-triazinan-1-yl]-3-bromanyl-propan-1-one | Formula: | C12 H18 Br3 N3 O3 | SMILES: | BrCCC(=O)N1CN(CN(C1)C(=O)CCBr)C(=O)CCBr | InChi: | InChI=1S/C12H18Br3N3O3/c13-4-1-10(19)16-7-17(11(20)2-5-14)9-18(8-16)12(21)3-6-15/h1-9H2 | Synonyms: | Chemical crosslinker | Definition date: | 2022-07-01 | Last modified: | 2024-09-27 | Release date: | 2023-09-20 | Identifier: | 1-[3,5-bis(3-bromanylpropanoyl)-1,3,5-triazinan-1-yl]-3-bromanyl-propan-1-one |
|
 | 2DG | Name: | 2-deoxy-alpha-D-galactopyranose | Formula: | C6 H12 O5 | SMILES: | OC1C(OC(O)CC1O)CO | InChi: | InChI=1S/C6H12O5/c7-2-4-6(10)3(8)1-5(9)11-4/h3-10H,1-2H2/t3-,4-,5+,6-/m1/s1 | Synonyms: | 2-deoxy-alpha-D-lyxo-hexopyranose | Definition date: | 2001-10-02 | Last modified: | 2024-09-27 | Identifier: | 2-deoxy-alpha-D-lyxo-hexopyranose |
|
 | 2DO | Name: | (2S)-2-AMINOHEXANE-1,1-DIOL | Formula: | C6 H15 N O2 | SMILES: | OC(O)C(N)CCCC | InChi: | InChI=1S/C6H15NO2/c1-2-3-4-5(7)6(8)9/h5-6,8-9H,2-4,7H2,1H3/t5-/m0/s1 | Definition date: | 2005-09-26 | Last modified: | 2024-09-27 | Identifier: | (2S)-2-aminohexane-1,1-diol |
|
 | 2DR | Name: | 2-deoxy-beta-D-erythro-pentofuranose | Formula: | C5 H10 O4 | SMILES: | OCC1OC(O)CC1O | InChi: | InChI=1S/C5H10O4/c6-2-4-3(7)1-5(8)9-4/h3-8H,1-2H2/t3-,4+,5+/m0/s1 | Synonyms: | 2-deoxy-beta-D-ribofuranose | Definition date: | 2009-07-20 | Last modified: | 2024-09-27 | Identifier: | 2-deoxy-beta-D-erythro-pentofuranose |
|
 | LGG | Name: | N-ACETYL-L-ALPHA-GLUTAMYL-L-PHENYLALANYL-L-GLUTAMINYL-N-[(1S)-4-AMINO-1-(2-CARBOXYETHYL)-4-OXOBUTYL]-L-LEUCINAMIDE | Formula: | C34 H51 N7 O11 | SMILES: | O=C(N)CCC(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C)CCC(=O)O)Cc1ccccc1)CCC(=O)N)CC(C)C)CCC(=O)O | InChi: | InChI=1S/C34H51N7O11/c1-19(2)17-25(33(51)38-22(9-13-27(35)43)10-15-29(45)46)40-32(50)24(11-14-28(36)44)39-34(52)26(18-21-7-5-4-6-8-21)41-31(49)23(37-20(3)42)12-16-30(47)48/h4-8,19,22-26H,9-18H2,1-3H3,(H2,35,43)(H2,36,44)(H,37,42)(H,38,51)(H,39,52)(H,40,50)(H,41,49)(H,45,46)(H,47,48)/t22-,23-,24-,25-,26-/m0/s1 | Definition date: | 2006-10-13 | Last modified: | 2024-09-27 | Identifier: | N-acetyl-L-alpha-glutamyl-L-phenylalanyl-L-glutaminyl-N-[(1S)-4-amino-1-(2-carboxyethyl)-4-oxobutyl]-L-leucinamide |
|
 | 2EI | Name: | 2-methyl-5-[[3-[1-[(3~{S},5~{R})-5-methyl-1-propanoyl-pyrrolidin-3-yl]-4-pyridin-4-yl-pyrazol-3-yl]phenoxy]methyl]-3~{H}-isoindol-1-one | Formula: | C32 H33 N5 O3 | SMILES: | CCC(=O)N1C[CH](C[CH]1C)n2cc(c3ccncc3)c(n2)c4cccc(OCc5ccc6c(CN(C)C6=O)c5)c4 | InChi: | InChI=1S/C32H33N5O3/c1-4-30(38)36-18-26(14-21(36)2)37-19-29(23-10-12-33-13-11-23)31(34-37)24-6-5-7-27(16-24)40-20-22-8-9-28-25(15-22)17-35(3)32(28)39/h5-13,15-16,19,21,26H,4,14,17-18,20H2,1-3H3/t21-,26+/m1/s1 | Definition date: | 2023-07-11 | Last modified: | 2024-09-27 | Release date: | 2024-06-05 | Identifier: | 2-methyl-5-[[3-[1-[(3~{S},5~{R})-5-methyl-1-propanoyl-pyrrolidin-3-yl]-4-pyridin-4-yl-pyrazol-3-yl]phenoxy]methyl]-3~{H}-isoindol-1-one |
|
 | 2EV | Name: | (3S,4S)-1-[(2-chlorophenyl)sulfonyl]-N-[(2E)-2-iminoethyl]-4-(morpholin-4-ylcarbonyl)pyrrolidine-3-carboxamide | Formula: | C18 H23 Cl N4 O5 S | SMILES: | O=C(N1CCOCC1)C3C(C(=O)NCC=[N@H])CN(S(=O)(=O)c2ccccc2Cl)C3 | InChi: | InChI=1S/C18H23ClN4O5S/c19-15-3-1-2-4-16(15)29(26,27)23-11-13(17(24)21-6-5-20)14(12-23)18(25)22-7-9-28-10-8-22/h1-5,13-14,20H,6-12H2,(H,21,24)/b20-5+/t13-,14-/m1/s1 | Definition date: | 2013-10-01 | Last modified: | 2024-09-27 | Release date: | 2014-08-20 | Identifier: | (3S,4S)-1-[(2-chlorophenyl)sulfonyl]-N-[(2E)-2-iminoethyl]-4-(morpholin-4-ylcarbonyl)pyrrolidine-3-carboxamide |
|
 | 2EW | Name: | (3S,4S)-N-[(2E)-2-iminoethyl]-4-(morpholin-4-ylcarbonyl)-1-(phenylsulfonyl)pyrrolidine-3-carboxamide | Formula: | C18 H24 N4 O5 S | SMILES: | O=C(N1CCOCC1)C3C(C(=O)NCC=[N@H])CN(S(=O)(=O)c2ccccc2)C3 | InChi: | InChI=1S/C18H24N4O5S/c19-6-7-20-17(23)15-12-22(28(25,26)14-4-2-1-3-5-14)13-16(15)18(24)21-8-10-27-11-9-21/h1-6,15-16,19H,7-13H2,(H,20,23)/b19-6+/t15-,16-/m1/s1 | Definition date: | 2013-10-01 | Last modified: | 2024-09-27 | Release date: | 2014-09-10 | Identifier: | (3S,4S)-N-[(2E)-2-iminoethyl]-4-(morpholin-4-ylcarbonyl)-1-(phenylsulfonyl)pyrrolidine-3-carboxamide |
|
 | LGY | Name: | (E)-N~6~-(4-oxobutylidene)-L-lysine | Formula: | C10 H18 N2 O3 | SMILES: | O=C(O)C(N)CCCC/N=C/CCC=O | InChi: | InChI=1S/C10H18N2O3/c11-9(10(14)15)5-1-2-6-12-7-3-4-8-13/h7-9H,1-6,11H2,(H,14,15)/b12-7+/t9-/m0/s1 | Definition date: | 2010-07-16 | Last modified: | 2024-09-27 | Identifier: | (E)-N~6~-(4-oxobutylidene)-L-lysine |
|
 | LH2 | Name: | 4-[[(3~{S})-1-oxidanyl-3,4-dihydro-2,1-benzoxaborinin-3-yl]methylamino]benzenecarboximidamide | Formula: | C16 H18 B N3 O2 | SMILES: | NC(=N)c1ccc(NC[CH]2Cc3ccccc3B(O)O2)cc1 | InChi: | InChI=1S/C16H18BN3O2/c18-16(19)11-5-7-13(8-6-11)20-10-14-9-12-3-1-2-4-15(12)17(21)22-14/h1-8,14,20-21H,9-10H2,(H3,18,19)/t14-/m0/s1 | Definition date: | 2019-08-15 | Last modified: | 2024-09-27 | Release date: | 2019-09-25 | Identifier: | 4-[[(3~{S})-1-oxidanyl-3,4-dihydro-2,1-benzoxaborinin-3-yl]methylamino]benzenecarboximidamide |
|
 | 2F3 | Name: | 1-[(2-chloroquinolin-3-yl)methyl]-6-fluoro-5-methyl-3-(2-oxo-1,2-dihydropyridin-3-yl)-1H-indole-2-carboxylic acid | Formula: | C25 H17 Cl F N3 O3 | SMILES: | O=C5NC=CC=C5c2c1cc(c(F)cc1n(c2C(=O)O)Cc3cc4ccccc4nc3Cl)C | InChi: | InChI=1S/C25H17ClFN3O3/c1-13-9-17-20(11-18(13)27)30(12-15-10-14-5-2-3-7-19(14)29-23(15)26)22(25(32)33)21(17)16-6-4-8-28-24(16)31/h2-11H,12H2,1H3,(H,28,31)(H,32,33) | Definition date: | 2013-10-07 | Last modified: | 2024-09-27 | Release date: | 2013-12-11 | Identifier: | 1-[(2-chloroquinolin-3-yl)methyl]-6-fluoro-5-methyl-3-(2-oxo-1,2-dihydropyridin-3-yl)-1H-indole-2-carboxylic acid |
|
 | LH5 | Name: | 4-[(3~{S})-1-oxidanyl-3,4-dihydro-2,1-benzoxaborinin-3-yl]-2-(pyridin-3-ylmethoxy)benzenecarboximidamide | Formula: | C21 H20 B N3 O3 | SMILES: | NC(=N)c1ccc(cc1OCc2cccnc2)[CH]3Cc4ccccc4B(O)O3 | InChi: | InChI=1S/C21H20BN3O3/c23-21(24)17-8-7-16(11-20(17)27-13-14-4-3-9-25-12-14)19-10-15-5-1-2-6-18(15)22(26)28-19/h1-9,11-12,19,26H,10,13H2,(H3,23,24)/t19-/m0/s1 | Definition date: | 2019-08-15 | Last modified: | 2024-09-27 | Release date: | 2019-09-25 | Identifier: | 4-[(3~{S})-1-oxidanyl-3,4-dihydro-2,1-benzoxaborinin-3-yl]-2-(pyridin-3-ylmethoxy)benzenecarboximidamide |
|